Table 3. Subgroup analysis of the effect of intensive follow-up on overall survival.
Subgroup title | Trial | I2 | HR (95% CI) | P |
---|---|---|---|---|
Intensive follow-up strategy | ||||
Intensive frequency | 4 | 17% | 0.82 [0.69, 0.97] | 0.04 |
Intensive test | 4 | 0% | 1.07 [0.88, 1.31] | |
Frequency of follow-up | ||||
Short interval(≤3 months) | 9 | 11% | 0.75 [0.64, 0.87] | 0.02 |
Long interval (>3 months) | 4 | 0% | 0.96 [0.84, 1.11] | |
Using CEA | ||||
CEA | 5 | 0% | 0.97 [0.84, 1.13] | 0.66 |
No CEA | 1 | - | 0.90 [0.67, 1.21] | |
Using CT | ||||
CT | 7 | 0 | 0.93 [0.82, 1.06] | 0.57 |
No CT | 2 | 53% | 1.31 [0.40, 4.23] |